Simvastatin Reduces the Association of NMDA Receptors to Lipid Rafts
- 1 April 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 39 (4) , 1269-1275
Abstract
Background and Purpose— Excess brain extracellular glutamate induced by cerebral ischemia leads to neuronal death, mainly through overactivation of N-methyl- d -aspartate (NMDA) receptors. The cholesterol-lowering drugs statins have been reported to protect from NMDA-induced neuronal death but, so far, the mechanism underlying this protection remains unclear. Because NMDA receptors have been reported to be associated with the cholesterol-rich membrane domains known as lipid rafts, we have investigated the effect of treatments that deplete cholesterol levels on excitotoxicity and on association of NMDA receptors to lipid rafts. Methods— Primary neuronal cultures were pretreated with inhibitors of cholesterol synthesis and cholesterol, and NMDA-induced cell death was determined by measuring release of lactate dehydrogenase. Lipid raft fractions were isolated and Western blots were performed. Results— Treatment with the inhibitors of cholesterol synthesis simvastatin, which inhibits the first step of cholesterol synthesis, or AY9944, which inhibits the last step of cholesterol synthesis, protected neurons from NMDA-induced neuronal death by 70% and 54%, respectively. Treatment with these compounds reduced neuronal cholesterol levels by 35% and 13%, respectively. Simvastatin and AY9944 reduced the association of the subunit 1 of NMDA receptors (NMDAR1) to lipid rafts by 42% and 21%, respectively, and did not change total expression of NMDAR1. Addition of cholesterol reduced neuroprotection by statins and AY9944, and partially reverted the effect of simvastatin on the association of NMDAR1 to lipid rafts. Conclusions— These data demonstrate that reduction of cholesterol levels protects from NMDA-induced neuronal damage probably by reducing the association of NMDA receptors to lipid rafts.Keywords
This publication has 31 references indexed in Scilit:
- Lipid raft microdomains and neurotransmitter signallingNature Reviews Neuroscience, 2006
- Discontinuation of Statin Treatment in Stroke PatientsStroke, 2006
- Simvastatin prevents oxygen and glucose deprivation/reoxygenation‐induced death of cortical neurons by reducing the production and toxicity of 4‐hydroxy‐2E‐nonenalJournal of Neurochemistry, 2006
- Statins and StrokeJournal of Cerebral Blood Flow & Metabolism, 2005
- Increased phosphorylation and redistribution of NMDA receptors between synaptic lipid rafts and post‐synaptic densities following transient global ischemia in the rat brainJournal of Neurochemistry, 2005
- Neuroprotective effects of atorvastatin against glutamate‐induced excitotoxicity in primary cortical neuronesJournal of Neurochemistry, 2005
- Protection by cholesterol‐extracting cyclodextrins: a role for N‐methyl‐d‐aspartate receptor redistributionJournal of Neurochemistry, 2005
- Association of Excitatory Amino Acid Transporters, Especially EAAT2, with Cholesterol-rich Lipid Raft MicrodomainsJournal of Biological Chemistry, 2004
- Prediction of Malignant Course in MCA Infarction by PET and MicrodialysisStroke, 2003
- Limiting Ischemic Injury by Inhibition of Excitatory Amino Acid ReleaseJournal of Cerebral Blood Flow & Metabolism, 1993